CN1732996A - 含有纳米级珍珠粉的口服液 - Google Patents
含有纳米级珍珠粉的口服液 Download PDFInfo
- Publication number
- CN1732996A CN1732996A CNA2004100537963A CN200410053796A CN1732996A CN 1732996 A CN1732996 A CN 1732996A CN A2004100537963 A CNA2004100537963 A CN A2004100537963A CN 200410053796 A CN200410053796 A CN 200410053796A CN 1732996 A CN1732996 A CN 1732996A
- Authority
- CN
- China
- Prior art keywords
- margarita
- liquid
- oral liquid
- nano
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 133
- 239000000843 powder Substances 0.000 title claims abstract description 68
- 244000293323 Cosmos caudatus Species 0.000 claims description 60
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- 239000000725 suspension Substances 0.000 claims description 25
- 241001116389 Aloe Species 0.000 claims description 23
- 235000011399 aloe vera Nutrition 0.000 claims description 23
- 239000012153 distilled water Substances 0.000 claims description 23
- 238000002360 preparation method Methods 0.000 claims description 19
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 15
- 235000010234 sodium benzoate Nutrition 0.000 claims description 15
- 239000004299 sodium benzoate Substances 0.000 claims description 15
- 230000002421 anti-septic effect Effects 0.000 claims description 14
- 230000008595 infiltration Effects 0.000 claims description 11
- 238000001764 infiltration Methods 0.000 claims description 11
- 239000001509 sodium citrate Substances 0.000 claims description 11
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 7
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 230000008030 elimination Effects 0.000 claims description 5
- 238000003379 elimination reaction Methods 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- -1 fatty acid ester Chemical class 0.000 claims description 5
- 239000004302 potassium sorbate Substances 0.000 claims description 5
- 235000010241 potassium sorbate Nutrition 0.000 claims description 5
- 229940069338 potassium sorbate Drugs 0.000 claims description 5
- 239000013049 sediment Substances 0.000 claims description 5
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 239000008347 soybean phospholipid Substances 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 4
- 238000001256 steam distillation Methods 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 229920002907 Guar gum Polymers 0.000 claims description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000000665 guar gum Substances 0.000 claims description 3
- 235000010417 guar gum Nutrition 0.000 claims description 3
- 229960002154 guar gum Drugs 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 239000001587 sorbitan monostearate Substances 0.000 claims description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 claims description 2
- 229940035048 sorbitan monostearate Drugs 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000013923 monosodium glutamate Nutrition 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 229940073490 sodium glutamate Drugs 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200410053796A CN1732996B (zh) | 2004-08-12 | 2004-08-12 | 含有纳米级珍珠粉的口服液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200410053796A CN1732996B (zh) | 2004-08-12 | 2004-08-12 | 含有纳米级珍珠粉的口服液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1732996A true CN1732996A (zh) | 2006-02-15 |
CN1732996B CN1732996B (zh) | 2010-05-26 |
Family
ID=36075751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200410053796A Expired - Fee Related CN1732996B (zh) | 2004-08-12 | 2004-08-12 | 含有纳米级珍珠粉的口服液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1732996B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744971B (zh) * | 2008-12-18 | 2011-09-21 | 杨玉红 | 一种美容祛斑组合液及其制备方法 |
CN101861990B (zh) * | 2010-01-21 | 2012-07-04 | 海南京润珍珠生物技术股份有限公司 | 珍珠维生素c含片 |
CN103055063A (zh) * | 2013-01-11 | 2013-04-24 | 太原市澳意医药生物科技有限公司 | 芦荟珍珠粉方便粒 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1416821A (zh) * | 2001-11-07 | 2003-05-14 | 焦柏忠 | 纳米级珍珠制品及其制作方法 |
CN1165316C (zh) * | 2001-11-13 | 2004-09-08 | 浙江大学 | 纳米级珍珠粉的制备方法 |
CN1404820A (zh) * | 2002-10-25 | 2003-03-26 | 谢永恒 | 一种嫩肤美容液 |
CN1172686C (zh) * | 2003-05-23 | 2004-10-27 | 詹碗媚 | 一种制备珍珠纳米材料的方法 |
-
2004
- 2004-08-12 CN CN200410053796A patent/CN1732996B/zh not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744971B (zh) * | 2008-12-18 | 2011-09-21 | 杨玉红 | 一种美容祛斑组合液及其制备方法 |
CN101861990B (zh) * | 2010-01-21 | 2012-07-04 | 海南京润珍珠生物技术股份有限公司 | 珍珠维生素c含片 |
CN103055063A (zh) * | 2013-01-11 | 2013-04-24 | 太原市澳意医药生物科技有限公司 | 芦荟珍珠粉方便粒 |
Also Published As
Publication number | Publication date |
---|---|
CN1732996B (zh) | 2010-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1045162C (zh) | 治疗肿瘤病药品的制备方法 | |
CN1216635C (zh) | 治疗糖尿病的组合物与方法 | |
CN1457808A (zh) | 一种铁皮石斛复方制剂及制备和应用 | |
CN1094302A (zh) | 一种纯中药口服液 | |
CN1067538C (zh) | 一种保健粉剂 | |
CN1927331A (zh) | 一种治疗慢性心力衰竭的中药制剂 | |
CN1328841A (zh) | 一种预防和治疗骨质疏松及促进骨折愈合的药物及其生产方法 | |
CN1732996A (zh) | 含有纳米级珍珠粉的口服液 | |
CN1253159C (zh) | 一种复合蜂胶保健品及其制备方法 | |
CN1195534C (zh) | 担子菌亚门和五加科提取物的生理活性组合物 | |
CN1186091C (zh) | 一种治疗肝病的注射液及其生产工艺 | |
CN1268323C (zh) | 一种圣地红景天软胶囊制剂及其制备方法 | |
CN1291735C (zh) | 一种活血化瘀,行气止痛的中药滴丸制剂 | |
CN1108162C (zh) | 一种男士补益壮元酒及制备方法 | |
CN1240297C (zh) | 肽奶及其制备工艺 | |
CN1172711C (zh) | 治疗慢性结膜炎的中药制剂 | |
CN1225175C (zh) | 降糖牛奶及其制造方法 | |
CN1201774C (zh) | 一种治疗高脂血症的药物 | |
CN1197580C (zh) | 一种治疗呼吸系统疾病的含贝母总碱的药物及其制备方法 | |
CN1299585C (zh) | 一种预防和改善心脑血管疾病的奶粉和其制造方法 | |
CN1679810A (zh) | 一种玄参总苷提取物及其制备方法和在制药中的应用 | |
CN1714660A (zh) | 一种豆奶粉及其制备方法 | |
CN1451395A (zh) | 一种蚕砂提取物治疗缺铁性贫血的应用 | |
CN1732896A (zh) | 一种纳米珍珠喷雾剂及其制备方法 | |
CN100349567C (zh) | (-)-表没食子儿茶素没食子酸酯-镁络合物固体分散体及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 311804 Zhejiang, Zhuji City Industrial Park under the lake Patentee after: PURE PEARL GROUP Co.,Ltd. Address before: 311804 Zhejiang, Zhuji City Industrial Park under the lake Patentee before: Zhejiang Shanxiahu Pearl Group Co.,Ltd. |
|
CP03 | Change of name, title or address |
Address after: 311804 Zheng, Hu Cun, Yamashita Lake Town, Zhejiang, Zhuji Patentee after: Innovative healthcare management Limited by Share Ltd. Address before: 311804 Zhejiang, Zhuji City Industrial Park under the lake Patentee before: PURE PEARL GROUP Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170804 Address after: 311804 Zhejiang city of Zhuji Province Pearl Characteristic Industrial Park Patentee after: Zhejiang Yinggelai Pharmacy Co.,Ltd. Address before: 311804 Zheng, Hu Cun, Yamashita Lake Town, Zhejiang, Zhuji Patentee before: Innovative healthcare management Limited by Share Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100526 Termination date: 20180812 |